普拉洛芬

普拉洛芬（CAS 52549-17-4）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.

同义词与商品名

pranoprofen; 52549-17-4; pyranoprofen; Pranoprofeno; Pranoprofene; Pranoprofenum; Elicapric; DTXSID1023497; NSC-759832; 2R7O1ET613; DTXCID603497; alpha-Methyl-5H-(1)benzopyrano(2,3-b)pyridine-7-acetic acid; (+-)-Pranoprofen; RefChem:868380; S01BC09; (2RS)-2-(10H-9-Oxa-1-azaanthracen-6-yl)propanoic acid

GHS 危害分类

Reported hazard statements	H301 (100%), H315 (33.3%), H319 (33.3%)

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

H315 (33.3%): Causes skin irritation [Warning Skin corrosion/irritation]

公开数据库对它的描述

Pranoprofen · CAS 52549-17-4 · C15H13NO3. UNII 2R7O1ET613.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。